The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy. (Q34956064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

review article

1 reference

title

The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

cervix uterine cancer

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Gretchen L Eiben

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Markwin P Velders

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

113-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Alterations in cytokine/antioncogene expression in skin lesions caused by "low-risk" types of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

New insights into T-cell antigen receptor structure and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

HLA-DQB1*03 and cervical intraepithelial neoplasia type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

The use of human leucocyte antigen class I transgenic mice to investigate human immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Tumor Heterogeneity and Immunotherapy of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Detection and characterization of human papillomavirus type 45 DNA in the cervical carcinoma cell line MS751.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

CD4 lymphocytes in women with invasive and preinvasive cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Therapeutic potential of protein and adjuvant vaccinations on tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Tumour-infiltrating lymphocytes in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

A link between cyclin A expression and adhesion-dependent cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cytokine profile of cervical cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cellular immunity against human papillomavirus associated cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

1 reference

7 January 2021

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immunity to oncogenic human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Role of oncogenes in the regulation of MHC antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Relationship Between Types of Human Papillomavirus and Langerhans’ Cells in Cervical Condyloma and Intraepithelial Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Functions of CD8 T-cell subsets secreting different cytokine patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Decreased frequency of HLA-DRB 1*13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus infection and genital warts: update on epidemiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus infection in women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Precision about the association between cervical carcinoma and HLA-DQB1*03 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Serologic response in human papillomavirus-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Signaling defects in T lymphocytes of patients with malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2986004-3

7 January 2021

10.1016/S0065-230X(02)86004-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12374277%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference